http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109385475-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
| filingDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109385475-B |
| titleOfInvention | Product for evaluating effect of propranolol on treating infantile hemangioma |
| abstract | The invention belongs to the field of medicines, and particularly relates to a product for evaluating the effect of propranolol on treating infantile hemangioma. The product is a kit, device, operable system, and/or combination thereof, the product comprising: (1) reagents, instruments and/or systems for determining the abundance of ID1 and β -actin expression in a subject's cell; (2) a module and/or processor for calculating the relative expression of ID 1; (3) a module and/or processor for assessing the effect of propranolol on treatment of infantile hemangiomas in a subject based on the relative expression of ID 1. The invention provides an effective evaluation method for finding out whether the infant hemangioma patient has drug resistance to propranolol as early as possible and effectively evaluating the treatment effect of propranolol on the infant hemangioma. |
| priorityDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.